Form 4: Cerence Inc. Director Sells 5,000 Shares Under 10b5-1 Trading Plan

A Cerence Inc. director, Thomas L Beaudoin, sold 5,000 shares of common stock at $7.36 per share on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Thomas L Beaudoin, a director at Cerence Inc., sold 5,000 shares of common stock on December 2, 2024.
• The sale was executed at a price of $7.36 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan that was adopted on December 21, 2023.
• Following the sale, Mr. Beaudoin directly owns 183,966 shares of Cerence Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of an insider transaction and is common for publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent material non-public information.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading disclosures.
• The use of a 10b5-1 trading plan is a common method for corporate insiders to sell shares without raising concerns about insider trading.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on investor sentiment, but the pre-planned nature of the sale mitigates any significant concerns.

Key Dates

Keywords

Cerence Inc., insider trading, Form 4, stock sale, 10b5-1 plan, director, equity securities